This contradiction may result from several different factors and may suggest that rather than an initiating factor in PAAD progression, NLRP1 overexpression may act as a response to restrict the growth and expansion of PAAD tumors at a particular stage to a certain level. The gene discussed is NLRP1; the disease is pancreatic adenocarcinoma.